Sharon Townson
Chief Tech/Sci/R&D Officer bij MONTE ROSA THERAPEUTICS, INC.
Profiel
Sharon Townson is currently the Chief Technology Officer at Monte Rosa Therapeutics, Inc. She previously worked as the Scientific Director-Physical Biochemistry at Warp Drive Bio, Inc. from 2016 to 2018 and as the Executive Director & Head-Platform Biology at Kymera Therapeutics, Inc. from 2019 to 2020.
Dr. Townson obtained her undergraduate degree from the University of Salford and her doctorate degree from the University of Manchester Institute of Science & Technology.
Actieve functies van Sharon Townson
Bedrijven | Functie | Begin |
---|---|---|
MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
Eerdere bekende functies van Sharon Townson
Bedrijven | Functie | Einde |
---|---|---|
KYMERA THERAPEUTICS, INC. | Director/Board Member | 01-06-2020 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-12-2018 |
Opleiding van Sharon Townson
University of Salford | Undergraduate Degree |
University of Manchester Institute of Science & Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
KYMERA THERAPEUTICS, INC. | Health Technology |
MONTE ROSA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |